Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-043221

Options or other derivatives

  • Director acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HILZINGER KURT J Director 2020-07-17 Grant or award · Stock Option (Right to Buy) +210,000 210,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…